139 related articles for article (PubMed ID: 8741511)
1. [A basic and clinical evaluation of a new immunoradiometric assay kit for human serum tissue polypeptide antigen (TPA)].
Shimojo K; Watanabe N; Sakai S; Kobayashi M; Ohtake H; Hatori N; Fukasawa K; Tomiyoshi K; Inoue T; Endo K
Kaku Igaku; 1996 Jun; 33(6):655-61. PubMed ID: 8741511
[TBL] [Abstract][Full Text] [Related]
2. [Evaluation of BEKI TPS radioassay kit as a one-step immunoradiometric assay utilizes monoclonal and polyclonal antibodies specific for serum tissue polypeptide antigen].
Hamase A; Kawanaka M; Kitani H; Fukuchi M
Kaku Igaku; 1994 Aug; 31(8):995-1003. PubMed ID: 7933689
[TBL] [Abstract][Full Text] [Related]
3. Tissue polypeptide antigen and tissue polypeptide specific antigen in primary breast cancer. Evaluation in serum and tumour tissue.
Gion M; Mione R; Barioli P; Sartorello P; Capitanio G
Eur J Clin Chem Clin Biochem; 1994 Oct; 32(10):779-87. PubMed ID: 7865616
[TBL] [Abstract][Full Text] [Related]
4. [Evaluation of a cytokeratin 19 assay kit "BALL ELSA CYFRA21-1"].
Sakahara H; Kousaka T; Hattori N; Hosono M; Kobayashi H; Shirato M; Yao Z; Konishi J
Kaku Igaku; 1993 Dec; 30(12):1475-9. PubMed ID: 7509008
[TBL] [Abstract][Full Text] [Related]
5. [Basic and clinical studies of serum CA195 antigen assay with "BL-CA195" kit].
Kobayashi M; Yamaguchi A; Imai T; Otake H; Igarashi H; Hatori N; Tomiyoshi K; Inoue T; Endo K; Sakahara H
Kaku Igaku; 1993 Apr; 30(4):441-7. PubMed ID: 8315895
[TBL] [Abstract][Full Text] [Related]
6. Serum tissue polypeptide antigen (TPA): monoclonal or polyclonal radio-immunometric assay for the follow-up of bladder cancer.
Bennink R; Van Poppel H; Billen J; Decoster M; Baert L; Mortelmans L; Blanckaert N
Anticancer Res; 1999; 19(4A):2609-13. PubMed ID: 10470203
[TBL] [Abstract][Full Text] [Related]
7. [Basic study of CA125 measurement using a newly developed "SD-8729" IRMA kit].
Yamaguchi A; Kobayashi M; Imai T; Otake H; Matsubara K; Hatori N; Tomiyoshi K; Inoue T; Endo K
Kaku Igaku; 1993 Oct; 30(10):1245-52. PubMed ID: 8264116
[TBL] [Abstract][Full Text] [Related]
8. In vitro effect of contrast agents during immunoradiometric assay for tumour-associated antigens.
Watanabe N; Oriuchi N; Higuchi T; Yukihiro M; Fukushima Y; Tomiyoshi K; Hirano T; Inoue T; Endo K
Nucl Med Commun; 1998 Jan; 19(1):63-70. PubMed ID: 9515548
[TBL] [Abstract][Full Text] [Related]
9. [Measurement of serum tissue polypeptide antigen (TPA) in patients with malignant tumor using prolifigen TPA-M "Daiichi" kit].
Sakahara H; Endo K; Torizuka K; Itoh K; Ohuchi N; Inaba N; Miyaji Y; Takayama M; Ishii K; Takagi H; Konishi J; Fukuoka M; Fukuchi M; Ohkawa J; Kagawa S; Kondo S; Shirouzu K; Iguchi H
Gan To Kagaku Ryoho; 1996 May; 23(6):733-43. PubMed ID: 8645025
[TBL] [Abstract][Full Text] [Related]
10. [Clinical evaluation of TPA-assay kit using monoclonal antibodies].
Saga T; Sakahara H; Kousaka T; Yao Z; Nakamoto Y; Hattori N; Zhang M; Nakayama M; Ohshio G; Imamura M; Konishi J
Gan To Kagaku Ryoho; 1996 Apr; 23(5):615-21. PubMed ID: 8678521
[TBL] [Abstract][Full Text] [Related]
11. [Basic and clinical studies on serum cytokeratin 19 fragment assay using Centocor CYFRA 21-1 kit in patients with lung cancer].
Hamase A; Sugimoto Y; Maeda M; Kitani H; Fukuchi M
Kaku Igaku; 1994 Aug; 31(8):969-76. PubMed ID: 7523748
[TBL] [Abstract][Full Text] [Related]
12. [An immunoradiometric assay of the serum TPA from patients with primary lung cancer and a comparison with the conventional double antibody method].
Suzuki K; Reshad K; Akiyama J; Itoi K; Hirata T; Muro K
Nihon Kyobu Shikkan Gakkai Zasshi; 1989 Jun; 27(6):703-11. PubMed ID: 2552212
[TBL] [Abstract][Full Text] [Related]
13. Development of a new Prolifigen TPA IRMA assay using monoclonal anti-cytokeratin antibodies.
Sundström BE; D'Amico Y; Brundell J
Int J Biol Markers; 1995; 10(3):166-73. PubMed ID: 8551060
[TBL] [Abstract][Full Text] [Related]
14. Clinical relevance of CYFRA 21-1, TPA-IRMA and TPA-LIA-mat in urinary bladder cancer.
Stieber P; Schmeller N; Schambeck C; Hofmann K; Reiter W; Hasholzner U; Fateh-Moghadam A
Anticancer Res; 1996; 16(6B):3793-8. PubMed ID: 9042259
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of tissue polypeptide antigen (TPA) plasma levels in patients with malignant salivary gland tumors.
Tanany H; Ezz M; Yassin S
Egypt Dent J; 1993 Jul; 39(3):505-6. PubMed ID: 9590978
[TBL] [Abstract][Full Text] [Related]
16. Serum tissue polypeptide antigen in bladder cancer as a tumor marker: a prospective study.
Maulard-Durdux C; Toubert ME; Hennequin C; Housset M
J Clin Oncol; 1997 Dec; 15(12):3446-50. PubMed ID: 9396396
[TBL] [Abstract][Full Text] [Related]
17. [The evaluation of the newly produced assay kit for the cytokeratin fragment, "ball ELSA CYFRA21-1"].
Kimura Y; Ata M; Nakamura S; Fujii T; Kawamura T; Tanada S; Hamamoto K
Kaku Igaku; 1994 Feb; 31(2):199-206. PubMed ID: 7509886
[TBL] [Abstract][Full Text] [Related]
18. [Basic studies of BALL ELSA CA125-II KIT for detection of serum cancer antigen 125].
Kakizaki J; Miyazaki T; Maeda T
Kaku Igaku; 1993 Jul; 30(7):807-12. PubMed ID: 8377304
[TBL] [Abstract][Full Text] [Related]
19. Serum TPS versus TPA in Egyptian bladder cancer patients.
Halim AB; el-Ahmady O; Hamza S; Aboul-Ela M; Oehr P
Int J Biol Markers; 1993; 8(4):221-6. PubMed ID: 7511149
[TBL] [Abstract][Full Text] [Related]
20. [Tissue polypeptide antigen (TPA)].
Sugiyama Y; Kawaguchi Y
Nihon Rinsho; 2005 Aug; 63 Suppl 8():705-7. PubMed ID: 16149617
[No Abstract] [Full Text] [Related]
[Next] [New Search]